Figures
Abstract
The epidermis is formed by layers of keratinocytes with increasing levels of differentiation towards the outer skin called skin barrier, which protects our body from environmental stressors and dehydration. When skin barrier is damaged, keratinocyte differentiation is triggered, and terminally differentiated keratinocytes express skin barrier components, achieving skin barrier homeostasis. However, the dynamic and quantitative understanding of how skin barrier homeostasis is achieved remains unknown. To elucidate how keratinocyte differentiation is dynamically affected by skin barrier damage, especially in the presence of infection, we developed a mechanistic model of keratinocyte differentiation by integrating experimental results from 101 manually curated publications. To extract the key regulatory structure of the model, we applied model reduction, called the kernel reduction methodology to obtain the minimal reaction network. The key regulatory structure is characterised by positive feedback with cooperativity between Np63 and Stat3, two master regulators of keratinocyte differentiation. This regulatory structure gives rise to bistable behaviour for the expression of terminal differentiation markers of keratinocytes when the skin barrier is damaged and the extracellular calcium level is varied. We validated the model by confirming it produces the history-dependent and switch-like keratinocyte differentiation observed in in vitro reversibility assays. Analysis of the validated model shows that bacterial infection augments keratinocytes’ sensitivity to skin barrier damage by decreasing the level required for differentiation and de-differentiation. Our results suggest the mechanisms by which skin barrier homeostasis is maintained even when the skin is exposed to fluctuating environments that perturb the barrier composition.
Author summary
We propose and validate a mechanistic mathematical model that can uncover how keratinocyte differentiation is affected by skin barrier damage and infection. Our model represents the key regulatory structure of the complex network of biochemical interactions that map infectious microenvironments to keratinocyte differentiation states. We identify a keratinocyte differentiation motif, the key regulatory structure of the model, by applying systematic model reduction. The motif comprises positive feedback and cooperativity, which gives rise to a bistable dose-response behaviour for keratinocyte differentiation in response to skin barrier damage. We validate our model by confirming it reproduces the results of in vitro keratinocyte differentiation assays. Model analysis shows that innate immune responses triggered by infection decreases the threshold levels required for differentiation and de-differentiation, making keratinocyte differentiation more sensitive to skin barrier damage. These results help elucidate how infectious skin microenvironments trigger the dynamic regulation of keratinocyte differentiation and understand the role of infection in skin diseases such as eczema and psoriasis on epidermal barrier homeostasis.
Citation: Domíguez-Hüttinger E, Flores-Garza E, Caldú-Primo JL, Day H, Roque Ramírez A, Tanaka RJ (2025) History-dependent switch-like differentiation of keratinocytes in response to skin barrier damage. PLoS Comput Biol 21(6): e1013162. https://doi.org/10.1371/journal.pcbi.1013162
Editor: Ricardo Martinez-Garcia, Center for Advanced Systems Understanding (CASUS), GERMANY
Received: September 9, 2024; Accepted: May 24, 2025; Published: June 9, 2025
Copyright: © 2025 Domíguez-Hüttinger et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The code and data are stored in our public GitHub repository: https://github.com/ElisaDominguezHuettinger/Keratinocyte_Differentiation.
Funding: EDH acknowledges funding from the Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT) UNAM IA207822 (https://dgapa.unam.mx/index.php/impulso-a-la-investigacion/papiit) and from CONACyT Ciencia de Frontera 2022 (https://conahcyt.mx/ciencia-de-frontera/), project number 319600. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
1. Introduction
The epidermis is a stratified epithelial tissue formed by layers of keratinocytes with increasing levels of differentiation. Terminally differentiated keratinocytes in the uppermost layer of the skin constitute the skin barrier, a physical and chemical barrier that protects our body from environmental aggressors [1]. The skin barrier is maintained by feedback regulation of keratinocyte differentiation. This feedback regulation is triggered by skin barrier damage [2–7] via activation of transcription factors and signalling molecules that induce expression of terminal differentiation markers [8–15]. Keratinocyte differentiation is also modulated by infection, which often accompanies skin barrier impairment [16–21]. Skin barrier homeostasis is the ability of skin to maintain its barrier function despite external perturbations. Loss of skin barrier homeostasis is associated with impaired terminal differentiation of keratinocytes that results in the formation of a deficient skin barrier, leading to pathological phenotypes such as atopic dermatitis, psoriasis, and cutaneous squamous cell carcinoma [22–24] in which increased pathogen loads prevail.
Here, we aim to understand how infection and skin barrier damage contribute to skin barrier homeostasis by elucidating how keratinocyte differentiation is regulated by skin barrier damage, especially in the presence of infection.
Clarifying and predicting the relationship between keratinocyte differentiation, skin barrier damage, and infection is challenging from a purely empirical perspective due to the difficulties in performing quantitative experiments at a cellular level in a stratified multi-layered tissue, despite recent advances in in vitro epidermal or full-thickness skin models [25]. Systems biology approaches, in which experimental data is integrated into predictive mathematical models, have proven to be effective in revealing the causal relationship between microenvironments and differentiation of, for example, T-cells [26], mesenchymal stem cells [26], and root stem cells [27]. However, mathematical models of dynamical processes for keratinocyte differentiation have been limited so far. Several regulatory networks of keratinocyte differentiation have been previously reconstructed at a cellular level using dynamical data from western blot experiments [28], public repositories [29], high throughput experiments [8] and, more recently, single-cell expression analysis [30,31]. However, these networks describe only the relationship between snapshot measurements without considering dynamical processes that are critical to elucidate causal relationships. As a result, the networks do not allow us to systematically analyse the effects of microenvironments on keratinocyte differentiation as they cannot reproduce the dynamical behaviour of keratinocyte differentiation.
In this paper, we propose a mechanistic model of keratinocyte differentiation that can predict the dynamic effect of microenvironments (characterised by levels and durations of skin barrier damage and infection) on keratinocyte differentiation. By integrating several experimental observations from published papers, the model describes how individual molecular players collectively contribute to keratinocyte differentiation, forming a regulatory network that maps microenvironments to keratinocytes’ differentiation states. We further propose a keratinocyte differentiation motif by distilling the essential regulatory features of the regulatory network and show that the motif demonstrates a history-dependent switch-like differentiation of keratinocytes in response to skin barrier damage.
2. Results
2.1. Construction of a regulatory network for keratinocyte differentiation
We constructed a regulatory network for keratinocyte differentiation to investigate how microenvironments (levels and durations of skin barrier damage and infection) affect keratinocyte differentiation (Fig 1A). The network structure was determined by integrating the findings from 101 manually curated relevant publications (Section A in S1 Text and S1 Table).
(A) Input-output relationship between microenvironmental signals and the expression of Terminal Differentiation Markers (TDM); (B) Regulatory network underlying keratinocyte differentiation. All regulations correspond to transcriptional events unless otherwise noted. PKC: Protein-Kinase C, EGFR: Epidermal Growth Factor Receptor.
The output of the network for keratinocyte differentiation is the expression level of Terminal Differentiation Markers (TDM) in keratinocytes, such as filaggrin (Flg), antimicrobial peptides (AMP), corneodesmosomes, and lipid processing enzymes. The high/low TDM expression level represents the differentiated/non-differentiated state of keratinocytes [32,33]. We consider the extracellular calcium level as the primary input of the regulatory network because its change is a major trigger of keratinocyte differentiation [15] as observed in in vitro calcium-switch experiments [34] and the extracellular calcium level rises in all epidermis layers upon skin barrier damage. The expression level of TDM [6,7] is altered by changes in the extracellular calcium level across the epidermis [35], especially for AMP [6,7], corneodesmosomes [28,36], and lipid processing enzymes [30,37]. As the second input of the regulatory network, we consider the concentration of active NFkB triggered by pathogen-induced innate immune responses, to evaluate the effects of infection on keratinocyte differentiation. Epidermal infection alters the calcium-mediated induction of keratinocyte differentiation [17–20,38–42] by interfering with the regulatory network.
The regulatory network for keratinocyte differentiation consists of 9 state variables: the Epidermal Growth Factor Receptor (EGFR), two AP1 transcription factors (cJun and JunB), p53, Np63, Notch, cMyc, miRNA203 and Stat3 (Fig 1B). These state variables are dynamically regulated with each other through transcriptional regulation, competitive inhibition, and post-translational and epigenetic modifications (detailed in Section A in S1 Text and in S1 Table).
To confirm that the regulatory network (Fig 1) robustly reproduces keratinocyte differentiation upon an increase in extracellular calcium levels, we formulate the network as an executable Boolean model (Section B and Fig A in S1 Text). This Boolean model allows us to describe the coupled dynamics of the nine state variables without requiring parameter values which are difficult to obtain for large systems. The model output is a discrete, quantitative and coarse-grained description of the all-or-nothing TDM response to an all-or-nothing calcium input. The deterministic steady states (fixed points and cyclic attractors) describe on/off patterns of the state variables that correspond to stable expression profiles triggered by different inputs.
The synchronous model simulation, under both low (basal) and high calcium conditions, finds four fixed point attractors, one of which corresponds to the differentiated state of keratinocytes with high TDM expression levels, and an additional two-state cyclic attractor that alternates between low and high TDM expression levels (Fig A(i,ii) in S1 Text). We confirmed that the four fixed point attractors are conserved under an asynchronous update regime (Fig A(iv) in S1 Text). The model has a much larger basin of attraction for the TDM state under the high, compared to the low (basal), calcium condition (Fig A(iii) in S1 Text), meaning that the differentiated state is much more likely to be observed under high calcium conditions (51.37% vs 7.42%). This result is consistent with that observed in calcium-switch experiments, where the population of differentiated keratinocytes increases dramatically upon increases in calcium [34].
2.2. Keratinocyte differentiation motif with positive feedback loops and cooperativity
The regulatory network (Fig 1) summarises most of the currently confirmed processes relevant to keratinocyte differentiation in response to skin barrier damage and infection. However, the network is too complex to fit to currently available experimental data (quantitative measurements of dynamic gene expression responses to inputs such as calcium and bacterial components) to quantitatively characterise how keratinocyte differentiation is affected by skin barrier damage and infection. We therefore reduced the network by applying the kernel reduction methodology [43] to obtain the minimal reaction network, which we refer to as the keratinocyte differentiation motif (Fig 2A). The kernel reduction is an algorithmic approach to identify the minimal essential network that preserves the input-output dynamics of the original network by sequentially removing intermediate nodes while keeping their regulatory interactions. We decided to remove all nodes of the regulatory network except for Stat3 and Np63. We kept Stat3 and Np63 because they directly regulate TDM, and their expression levels are measured in several calcium switch experiments. The details of the reduction process are described in Section D in S1 Text. We confirmed the minimality of the network as it robustly reproduces the experimentally observed dynamic and long-term responses to different pathological microenvironments, as detailed below, and this agreement with empirical observations is lost upon pruning further variables and interactions.
(A) Kinetic model. (B) Model fitting to TDM gene expression in response to a step increase in the calcium concentration (from 0.05 to 1.2 mM CaCl2); data from [8] represents the distribution (mean and standard deviation) over different terminal differentiation marker genes (SLPI, S100A7, and RNASE7, IVL and FLG), each of which was normalized by its maximal value. Error bars represent the dispersion (SD) of the individual genes. The steady state (TDMss) obtained by the model simulation is shown as a grey dotted line. (C) Validation of the kinetic model. The model reproduces the keratinocyte differentiation experiments from [44], in which a 3-day transient calcium challenge (shown in orange) is added to the medium and the reversion of keratinocyte differentiation is observed.
The keratinocyte differentiation motif consists of Stat3 and Np63 that directly regulate the TDM expression in response to the changes in the extracellular calcium level and infectious microenvironment (NFkB). An increase in the external calcium level (upon barrier damage) leads to an increase in Stat3 and a decrease in Np63 levels through molecular mechanisms described in Section A in S1 Text. Stat3 and Np63 increase each other’s level, forming a positive feedback loop. Np63 expression is induced by cooperative auto-induction, forming the second positive feedback loop (Fig 2A). The TDM expression is induced by the increase in the Np63 expression level and inhibited by the activated Stat3. The expression of Np63 is induced by innate immune responses, represented here by the NFkB level.
The kinetics of the keratinocyte differentiation motif is described by
where ,
and
represent the expression levels of Stat3, Np63 and TDM, respectively. The direct regulatory interactions are modelled by the law of mass action kinetics. Stat3 expression is induced by calcium with a constant rate,
, which is a lumped parameter representing the effects of calcium on the dynamics of Stat3, and by Np63 with a rate,
. We describe the auto-induction of Np63 expression by a Hill function (with a maximal rate,
, a half-maximal inductor concentration,
, and a Hill-coefficient,
) because it is mediated by the formation of protein complexes. Induction of Np63 expression via a Stat3-dependent and NFkB-dependent pathways are described with rates,
and
, respectively. Expression of TDM is inhibited by Stat3 with rate,
, and is augmented by Np63 methylation of their promoters [45–47]. It is modelled with the convolution of
with a decaying exponential
with maximal rate,
, and the exponent,
, quantifying the memory of the methylation. The natural degradation of Stat3, Np63 and TDM are described by the rates,
,
and
, respectively. Np63 degradation is also calcium-dependent with a weighting,
. We obtained the kinetic model parameters by minimising the difference between the model simulation and the dynamic experimental data from primary human keratinocytes [8] using a global optimisation algorithm (Table 1). The fitted model captures a slow steady increase of TDM expression in keratinocytes (AMP SLPI, S100A7, RNASE, filaggrin and involucrin) [8] for 48h upon calcium challenge (Fig 2B and Fig C in S1 Text).
We validated our model with calibrated parameters by confirming that the model dynamics reflect the qualitative dynamical behaviour of the reversible keratinocyte differentiation assays [44] (Fig 2C), the decaying dynamics of Np63 expression observed in two independent experiments [8,48] (Fig D in S1 Text), and the dynamics of filaggrin expression observed in a keratinocyte differentiation assay in human normal epidermal keratinocytes [36] (Fig E in S1 Text).
2.3. Switch-like and history-dependent keratinocyte differentiation in response to change in the extracellular calcium level
We demonstrated that the kinetic model of keratinocyte differentiation shows a bistable behaviour by deriving the nullclines of the 2D Np63-Stat3 projection of the model (Section E in S1 Text). The two stable steady states in our model are visualised as the points of intersection between the Stat3 nullcline (a first-order polynomial) and the Np63 nullcline (a sigmoidal function) (Fig 3A). The effects of changing the calcium level (the primary input of our model) on the stable steady states are visualised on the Np63-Stat3 phase plane, onto which the state trajectories of the model can be projected as these two state variables are uncoupled from the output (TDM). We investigated the steady state behaviour of the model under low and high calcium concentrations by simulating varying levels of CaCl2 [mM], where the low calcium concentration corresponds to that typically used in in vitro calcium switch experiments, and the high concentration is one order of magnitude higher (Fig 3A). As the calcium level increases, the Stat3 nullcline shifts upwards while the Np63 nullcline straightens, eventually losing the low Np63 steady state. As a result, only the undifferentiated state with low Np63 is stable for low calcium conditions, while two steady states, corresponding to a low and a high Np63 (and Stat3), exist for medium calcium conditions.
(A) The Np63-Stat3 phase plane. Three intersection points of the Np63 and Stat3 nullclines for intermediate calcium levels correspond to two stable (filled stars) and one unstable (open blue star) steady states. Increasing the calcium levels shifts the Stat3 nullcline up and straightens the Np63 nullcline, leading to the loss of the low stable steady state. (B) Bifurcation diagrams for the three state variables as the extracellular calcium level as a bifurcation parameter. Bistabliltiy is observed between the threshold calcium concentrations C- and C + , at which an abrupt change in the state variables is observed.
Bifurcation analysis confirms the bistability for Np63, Stat3 and TDM with the calcium level as a bifurcation parameter between the threshold calcium concentrations, C- and C+ (Fig 3B). Increasing calcium concentration above the threshold, C+ , results in an abrupt increase in the levels of the state variables, which persists until the calcium concentration is decreased to a value below the second threshold, C-, at which an abrupt change from high to low is observed. The bistability is consistent with a reversible switch-like history-dependent keratinocyte differentiation observed in experimental studies in response to a change in the extracellular calcium level. For example, the TDM expression levels are stabilised eventually at a low or high state [36,49,50] after a transient change triggered by a change in the extracellular calcium level. When stabilised at a high state due to a sufficiently long-lasting increase in the calcium level, it remains at a high state for days after the extracellular calcium level decreases [44].
2.4. Modulation of keratinocyte differentiation by infection
To investigate how the infectious microenvironment modulates keratinocyte differentiation, we conducted a similar bifurcation analysis but with an increased level of active NFkB to mimic pathogen-induced innate immune responses (Fig 4). In the keratinocyte differentiation motif, an increase in the level of active NFkB leads to an increase in the Np63 production rate as NFkB increases the transcription rate of Np63 by inducing activation of p300 [51–53].
(A) Bifurcation diagrams for the 3 state variables (Stat3, Np63 and TDM) with three levels of NFkB (0, 0.1 and 0.25). The larger the NFkB level is, the smaller the activation threshold level for the calcium (C+), making the system more sensitive to barrier damage. (B) C+ linearly decreases with NFkB (variation of NFkB: 0:0.01:1).
Increasing NFkB in our model lowers the activation thresholds of calcium (C+) required for keratinocyte differentiation. A lower threshold represents the skin being more sensitive to barrier damage: more subtle barrier damage (a slight increase in the extracellular calcium level) is sufficient to trigger the TDM expression in the presence of NFkB. Small and transient barrier damage can lead to a burst in TDM. This result is consistent with the increased sensitivity of keratinocyte differentiation to barrier damage in the presence of pathogens [17–20,38–40,54].
3. Discussion
This paper proposed the first mechanistic model of keratinocyte differentiation. The model development comprised of network assembly, simulation, and validation of both the full and the minimal regulatory networks of keratinocyte differentiation.
To develop the mechanistic model, we first conducted an extensive literature search and assembled a regulatory network of intercellular interactions involved in keratinocyte differentiation. We then confirmed that calcium-triggered keratinocyte differentiation emerges from this network by dynamically simulating it using a Boolean network approach. As the whole network is too complex to analyse its dynamics, we derived the minimal regulatory network of keratinocyte differentiation by identifying the smallest set of variables and their interactions that can robustly reproduce the experimentally observed keratinocyte differentiation in response to calcium and infection. The resulting keratinocyte differentiation motif is then mathematically represented using kinetic ordinary differential equations. Model parameter values were obtained by global optimisation to fit the model to time-course data of calcium switch experiments. Bifurcation analysis of our model reproduces the abrupt history-dependent keratinocyte differentiation in response to the changes in the calcium level reported experimentally. Bifurcation analysis also showed that infection-induced immune responses shape the decision-making process of keratinocyte differentiation by shifting the extracellular calcium level thresholds required for stable TDM expression.
Our proposed keratinocyte differentiation motif comprises the smallest set of variables and their interactions that can reproduce various empirical observations of keratinocyte differentiation in response to calcium and infection derived from different experimental conditions. Adding more nodes could improve the model’s ability to capture more experimental results, including the deleterious effects of HPV [42,49,55] and inflammation [54,56,57] on keratinocyte differentiation. However, it would also add more parameters to the model. Given the scarcity of available quantitative and longitudinal data, obtaining reliable estimates for those parameters would be difficult. We hope our work will motivate experimentalists to generate more quantitative time-resolved measurements of keratinocyte differentiation.
In summary, our mathematical model analysis uncovered the keratinocyte differentiation motif, comprised of the interplay between Stat3 and Np63, as the key regulatory structure underlying keratinocyte differentiation in response to the changes in the extracellular calcium level. The response is modulated through infection-induced immune responses, as infection increases the sensitivity to calcium-mediated increase in TDM expression by increasing Np63 production.
Our work contributes to elucidating the decision-making processes underlying keratinocyte differentiation [15] and its role in shaping the homeostasis of the epidermis and other stratified epithelial tissues. Skin barrier homeostasis has been previously modelled using multi-scale models [58–60], which however do not consider the mechanisms of keratinocyte differentiation. The proposed minimal network of keratinocyte differentiation is mechanistic yet simple enough to be incorporated into such a multi-scale model of epidermal dynamics. It will be interesting to analyse the contribution of the tissue-level feedback from skin barrier function to keratinocyte differentiation and epidermal homeostasis and elucidate how the differentiation state of keratinocytes affects the immune response to pathogens (secretion of AMP) and barrier restoration in response to barrier damage and pathogen challenge. Such a model would contribute to the understanding of the mechanisms through which treatments to enhance keratinocyte differentiation directly (e.g., vitamin D [61]) or indirectly through interference with IL4 signalling (Dupilumab [62,63]) help the restoration of epidermal homeostasis in diseases such as atopic dermatitis and psoriasis.
4. Methods
4.1. Curation of dynamic data for epidermal differentiation markers
We assembled expression data of mRNAs (measured by qPCR and by microarray) and proteins (measured by Western Blot) from 14 references (S2 Table) to test the validity of our kinetic model of keratinocyte differentiation. It includes time-course data of the TDM (involucrin, fillagrin, transglutaminase [36,49,50,64], AMP HBD [7] and the internal regulators of epidermal differentiation (ΔNp63 [48] and pEGFR, cMyc and cJun [28]) in response to calcium challenges (a sudden increase from 0.05mM to 1.2mM or 1.3mM CaCl) under control conditions and inflammatory [56,64,65] or TLR-activating [16] microenvironmental conditions, as well as a reversibility experiment [44] through which the memory of keratinocyte differentiation can be quantitatively assessed.
4.2. Parameter optimisation of the kinetic model for keratinocyte differentiation
We used the GlobalSearch function in Matlab R2022a to minimise the difference between predicted and experimentally determined mean-over individual gene expression of the TDM: SLPI, S100A7 RNASE (AMP), and filaggrin and involucrin measured by Toufighi et al. [8]. Calcium switch experiments were simulated by increasing the values of Ca from 0.1 to 2.
Supporting information
S1 Table. Individual regulatory interactions underlying the regulatory network for keratinocyte differentiation in response to the changes in the extracellular calcium level modulated by infection assembled from 101 references.
https://doi.org/10.1371/journal.pcbi.1013162.s001
(XLSX)
S2 Table. Expression data of epidermal differentiation markers corresponding to levels of mRNAs (measured by qPCR and by microarray) or proteins (measured by Western Blot) assembled from 14 references.
https://doi.org/10.1371/journal.pcbi.1013162.s002
(XLSX)
S1 Text. The Supplementary Text contains Supplementary Sections A-F, Supplementary Figures A-F and Supplementary References.
https://doi.org/10.1371/journal.pcbi.1013162.s003
(PDF)
References
- 1. Goleva E, Berdyshev E, Leung DY. Epithelial barrier repair and prevention of allergy. J Clin Invest. 2019;129(4):1463–74. pmid:30776025
- 2. Zhang C, Merana GR, Harris-Tryon T, Scharschmidt TC. Skin immunity: dissecting the complex biology of our body’s outer barrier. Mucosal Immunol. 2022;15(4):551–61. pmid:35361906
- 3. Törmä H, Lindberg M, Berne B. Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol. 2008;128(5):1212–9. pmid:18007579
- 4. Grubauer G, Elias PM, Feingold KR. Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res. 1989;30(3):323–33. pmid:2723540
- 5. de Koning HD, van den Bogaard EH, Bergboer JGM, Kamsteeg M, van Vlijmen-Willems IMJJ, Hitomi K. Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair. Br J Dermatol. 2012;166(6):1245–54. pmid:22329734
- 6. Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, et al. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol. 2010;130(5):1355–64. pmid:20107483
- 7. Kisich KO, Carspecken CW, Fiéve S, Boguniewicz M, Leung DYM. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol. 2008;122(1):62–8. https://doi.org/10.1016/j.jaci.2008.04.022 pmid:18538383
- 8. Toufighi K, Yang J-S, Luis NM, Aznar Benitah S, Lehner B, Serrano L, et al. Dissecting the calcium-induced differentiation of human primary keratinocytes stem cells by integrative and structural network analyses. PLoS Comput Biol. 2015;11(5):e1004256. pmid:25946651
- 9. Oh IY, Albea DM, Goodwin ZA, Quiggle AM, Baker BP, Guggisberg AM, et al. Regulation of the dynamic chromatin architecture of the epidermal differentiation complex is mediated by a c-Jun/AP-1-modulated enhancer. J Invest Dermatol. 2014;134(9):2371–80. pmid:24468747
- 10. Niehues H, Tsoi LC, van der Krieken DA, Jansen PAM, Oortveld MAW, Rodijk-Olthuis D, et al. Psoriasis-Associated Late Cornified Envelope (LCE) Proteins Have Antibacterial Activity. Journal of Investigative Dermatology. 2017;137(11):2380–8. https://doi.org/10.1016/j.jid.2017.06.003 pmid:28634035
- 11. Meisel JS, Sfyroera G, Bartow-McKenney C, Gimblet C, Bugayev J, Horwinski J, et al. Commensal microbiota modulate gene expression in the skin. Microbiome. 2018;6(1):20. pmid:29378633
- 12. Percoco G, Merle C, Jaouen T, Ramdani Y, Bénard M, Hillion M, et al. Antimicrobial peptides and pro-inflammatory cytokines are differentially regulated across epidermal layers following bacterial stimuli. Exp Dermatol. 2013;22(12):800–6. pmid:24118337
- 13. Sayama K, Komatsuzawa H, Yamasaki K, Shirakata Y, Hanakawa Y, Ouhara K, et al. New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of beta-defensins, LL37, and TLR2. Eur J Immunol. 2005;35(6):1886–95. pmid:15864780
- 14. Fessing MY, Mardaryev AN, Gdula MR, Sharov AA, Sharova TY, Rapisarda V, et al. p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol. 2011;194(6):825–39. pmid:21930775
- 15. Mascia F, Denning M, Kopan R, Yuspa SH. The black box illuminated: signals and signaling. J Invest Dermatol. 2012;132(3 Pt 2):811–9. pmid:22170487
- 16. Borkowski AW, Park K, Uchida Y, Gallo RL. Activation of TLR3 in keratinocytes increases expression of genes involved in formation of the epidermis, lipid accumulation, and epidermal organelles. J Invest Dermatol. 2013;133(8):2031–40. pmid:23353987
- 17. Duckney P, Wong HK, Serrano J, Yaradou D, Oddos T, Stamatas GN. The role of the skin barrier in modulating the effects of common skin microbial species on the inflammation, differentiation and proliferation status of epidermal keratinocytes. BMC Res Notes. 2013;6:474. pmid:24245826
- 18. Lee SE, Kim JM, Jeong SK, Jeon JE, Yoon HJ, Jeong MK, et al. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Arch Dermatol Res. 2010;302(10):745–56. https://doi.org/10.1007/s00403-010-1074-z pmid:20697725
- 19. Dommisch H, Chung WO, Rohani MG, Williams D, Rangarajan M, Curtis M, et al . Protease-activated receptor 2 mediates human beta-defensin 2 and CC chemokine ligand 20 mRNA expression in response to proteases secreted by Porphyromonas gingivalis. Infect Immun. 2007;75(9):4326–33. https://doi.org/10.1128/IAI.00455-07 pmid:17591792
- 20. Abtin A, Eckhart L, Gläser R, Gmeiner R, Mildner M, Tschachler E. The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes. J Invest Dermatol. 2010;130(10):2423–30. pmid:20555353
- 21. Wanke I, Skabytska Y, Kraft B, Peschel A, Biedermann T, Schittek B. Staphylococcus aureus skin colonization is promoted by barrier disruption and leads to local inflammation. Exp Dermatol. 2013;22:153–5. https://doi.org/10.1111/exd.12083 pmid:23362876
- 22. Guttman-Yassky E, Suárez-Fariñas M, Chiricozzi A, Nograles KE, Shemer A, Fuentes-Duculan J, et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol. 2009;124(6):1235-1244.e58. pmid:20004782
- 23. Suárez-Fariñas M, Tintle SJ, Shemer A, Chiricozzi A, Nograles K, Cardinale I, et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol. 2011;127(4):954-64.e1-4. pmid:21388663
- 24. Winge MCG, Kellman LN, Guo K, Tang JY, Swetter SM, Aasi SZ, et al. Advances in cutaneous squamous cell carcinoma. Nat Rev Cancer. 2023;23(7):430–49. pmid:37286893
- 25. Meesters LD, Niehues H, Johnston L, Smits JPH, Zeeuwen PLJM, Brown SJ, et al. Keratinocyte signaling in atopic dermatitis: Investigations in organotypic skin models toward clinical application. J Allergy Clin Immunol. 2023;151(5):1231–5. pmid:36841264
- 26. Martinez-Sanchez ME, Mendoza L, Villarreal C, Alvarez-Buylla ER. A Minimal Regulatory Network of Extrinsic and Intrinsic Factors Recovers Observed Patterns of CD4+ T Cell Differentiation and Plasticity. PLoS Comput Biol. 2015;11(6):e1004324. pmid:26090929
- 27. Azpeitia E, Benítez M, Vega I, Villarreal C, Alvarez-Buylla ER. Single-cell and coupled GRN models of cell patterning in the Arabidopsis thaliana root stem cell niche. BMC Syst Biol. 2010;4:134. pmid:20920363
- 28. Saeki Y, Nagashima T, Kimura S, Okada-Hatakeyama M. An ErbB receptor-mediated AP-1 regulatory network is modulated by STAT3 and c-MYC during calcium-dependent keratinocyte differentiation. Exp Dermatol. 2012;21(4):293–8. https://doi.org/10.1111/j.1600-0625.2012.01453.x pmid:22417306
- 29. Yoon HK, Sohn K-C, Lee J-S, Kim YJ, Bhak J, Yang J-M, et al. Prediction and evaluation of protein-protein interaction in keratinocyte differentiation. Biochem Biophys Res Commun. 2008;377(2):662–7. pmid:18948079
- 30. Rubin AJ, Parker KR, Satpathy AT, Qi Y, Wu B, Ong AJ, et al. Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory Networks. Cell. 2019;176(1–2):361-376.e17. pmid:30580963
- 31. Cavazza A, Miccio A, Romano O, Petiti L, Malagoli Tagliazucchi G, Peano C, et al. Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation. Stem Cell Reports. 2016;6(4):618–32. pmid:27050947
- 32. Visscher MO, Carr AN, Narendran V. Epidermal immunity and function: origin in neonatal skin. Front Mol Biosci. 2022;9(June):1–18.
- 33. Leśniak W. Dynamics and epigenetics of the epidermal differentiation complex. Epigenomes. 2024;8(1). https://doi.org/10.3390/epigenomes8010009 pmid:38534793
- 34. Bikle DD, Xie Z, Tu C-L. Calcium regulation of keratinocyte differentiation. Expert Rev Endocrinol Metab. 2012;7(4):461–72. pmid:23144648
- 35. Lee SE, Lee SH. Skin Barrier and Calcium. Ann Dermatol. 2018;30(3):265–75. pmid:29853739
- 36. Borowiec AS, Delcourt P, Dewailly E, Bidaux G. Optimal Differentiation of In Vitro Keratinocytes Requires Multifactorial External Control. PLoS One. 2013;8(10):1–15. https://doi.org/10.1371/journal.pone.0077507 pmid:24116231
- 37. Koria P, Brazeau D, Kirkwood K, Hayden P, Klausner M, Andreadis ST. Gene expression profile of tissue engineered skin subjected to acute barrier disruption. J Invest Dermatol. 2003;121(2):368–82. pmid:12880430
- 38. Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V, Gatta GD, et al. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 2006;20(8):1028–42. https://doi.org/10.1101/gad.1406006 pmid:16618808
- 39. Sen T, Chang X, Sidransky D, Chatterjee A. Regulation of ΔNp63α by NFκΒ. Cell Cycle. 2010;9(24):4841–7. pmid:21088498
- 40. Wanke I, Steffen H, Christ C, Krismer B, Götz F, Peschel A, et al. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol. 2011;131(2):382–90. pmid:21048787
- 41. Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016;2:16086. pmid:27905473
- 42. Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T. Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol. 2007;27(10):3732–42. pmid:17353266
- 43. Kim J-R, Kim J, Kwon Y-K, Lee H-Y, Heslop-Harrison P, Cho K-H. Reduction of complex signaling networks to a representative kernel. Sci Signal. 2011;4(175):ra35. pmid:21632468
- 44. Jadali A, Ghazizadeh S. Protein kinase D is implicated in the reversible commitment to differentiation in primary cultures of mouse keratinocytes. J Biol Chem. 2010;285(30):23387–97. pmid:20463010
- 45. Botchkarev VA. The Molecular Revolution in Cutaneous Biology: Chromosomal Territories, Higher-Order Chromatin Remodeling, and the Control of Gene Expression in Keratinocytes. Journal of Investigative Dermatology. 2016;137(5):e93–9. https://doi.org/10.1016/j.jid.2016.04.040 pmid:28411854
- 46. Yi M, Tan Y, Wang L, Cai J, Li X, Zeng Z, et al. TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development. Cell Mol Life Sci. 2020;77(21):4325–46. pmid:32447427
- 47. Smirnov A, Lena AM, Cappello A, Panatta E, Anemona L, Bischetti S, et al. ZNF185 is a p63 target gene critical for epidermal differentiation and squamous cell carcinoma development. Oncogene. 2019;38(10):1625–38. pmid:30337687
- 48. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, Aberdam D, Knight RA, Melino G, et al. miR-203 represses “stemness” by repressing DeltaNp63. Cell Death Differ. 2008;15(7):1187–95. pmid:18483491
- 49. Dazard JE, Piette J, Basset-Seguin N, Blanchard JM, Gandarillas A. Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size. Oncogene. 2000;19(33):3693–705. https://doi.org/10.1038/sj.onc.1203695 pmid:10949923
- 50. Ogawa E, Okuyama R, Egawa T, Nagoshi H, Obinata M, Tagami H, et al. p63/p51-induced onset of keratinocyte differentiation via the c-Jun N-terminal kinase pathway is counteracted by keratinocyte growth factor. J Biol Chem. 2008;283(49):34241–9. pmid:18849344
- 51. MacPartlin M, Zeng S, Lee H, Stauffer D, Jin Y, Thayer M, et al. p300 regulates p63 transcriptional activity. J Biol Chem. 2005;280(34):30604–10. pmid:15965232
- 52. Katoh I, Maehata Y, Moriishi K, Hata RI, Kurata SI. C-terminal α Domain of p63 Binds to p300 to Coactivate β-Catenin. Neoplasia. 2019;21(5):494–503. pmid:30986748
- 53. Wang H, Moreau F, Hirota CL, MacNaughton WK. Proteinase‐activated receptors induce interleukin‐8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation. FASEB Journal. 2010;24(6):1971–80. https://doi.org/10.1096/fj.09-137646 pmid:20065107
- 54. Kim BE, Howell MD, Guttman-Yassky E, Gilleaudeau PM, Cardinale IR, Boguniewicz M, et al. TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier. J Invest Dermatol. 2011;131(6):1272–9. pmid:21346775
- 55. McKenna DJ, McDade SS, Patel D, McCance DJ. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J Virol. 2010;84(20):10644–52. pmid:20702634
- 56. Howell MD, Fairchild HR, Kim BE, Bin L, Boguniewicz M, Redzic JS, et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol. 2008;128(9):2248–58. pmid:18385759
- 57. Kim L, Leung B, Boguniewicz M, Howell M. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clinical Immunology. 2008;126(3):332–7. https://doi.org/10.1016/j.clim.2007.11.006 pmid:18166499
- 58. Domínguez-Hüttinger E, Christodoulides P, Miyauchi K, Irvine AD, Okada-Hatakeyama M, Kubo M, et al. Mathematical modeling of atopic dermatitis reveals “double-switch” mechanisms underlying 4 common disease phenotypes. J Allergy Clin Immunol. 2017;139(6):1861–72.e7. pmid:27931974
- 59. Cursons J, Gao J, Hurley DG, Print CG, Dunbar PR, Jacobs MD, et al. Regulation of ERK-MAPK signaling in human epidermis. BMC Syst Biol. 2015;9:41. pmid:26209520
- 60. Sütterlin T, Huber S, Dickhaus H, Grabe N. Modeling multi-cellular behavior in epidermal tissue homeostasis via finite state machines in multi-agent systems. Bioinformatics. 2009;25(16):2057–63. pmid:19535533
- 61. Mason A, Mason J, Cork M, Dooley G. Topical treatments for chronic plaque psoriasis. Cochrane Database of Systematic Reviews. 2013(3):1–798. https://doi.org/10.1016/j.jaad.2013.06.027 pmid:24124809
- 62. Frazier W, Bhardwaj N. Atopic Dermatitis: Diagnosis and Treatment. American Family Physician. 2020;101:590–8. pmid:32412211
- 63. Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016;375(24):2335–48. pmid:27690741
- 64. Serezani APM, Bozdogan G, Sehra S, Walsh D, Krishnamurthy P, Sierra Potchanant EA, et al. IL-4 impairs wound healing potential in the skin by repressing fibronectin expression. J Allergy Clin Immunol. 2017;139(1):142–51.e5. pmid:27554818
- 65. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007;120(1):150–5. pmid:17512043